J
Janssen Vaccines
Vaccine development and manufacturing using proprietary platforms
At a glance
- Status
- Listed
- Founded
- 2000
- Headquarters
- Leiden, Netherlands
- Listing
- IPO 2000
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series B and later1 investor entered at this stage
- LULeiden University
Source: Dealroom Talent Intelligence.
Alumni founders
Former Janssen Vaccines employees who went on to found companies, sorted by Dealroom signal score.
MYmyTomorrowsEst. 2012
Ronald BrusNetherlands
Björn SjöstrandSweden
Steena Sunyong LeeSouth Korea
LLLeyden LabsEst. 2020
Dinko ValerioNetherlands
QUQurAlisEst. 2016
Kasper RoetUnited StatesGlobal footprint
across markets
Patents
3,990 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Janssen Vaccines on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Janssen Vaccines on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
